These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 22816783)

  • 21. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation.
    Kubota K; Onishi K; Sawaki K; Li T; Mitsuoka K; Sato T; Takeoka S
    Int J Nanomedicine; 2017; 12():5121-5133. PubMed ID: 28790820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-Particle Spectroscopic Chromatography Reveals Heterogeneous RNA Loading and Size Correlations in Lipid Nanoparticles.
    Li S; Hu Y; Lin J; Schneiderman Z; Shao F; Wei L; Li A; Hsieh K; Kokkoli E; Curk T; Mao HQ; Wang TH
    ACS Nano; 2024 Jun; 18(24):15729-15743. PubMed ID: 38839059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery.
    He Z; Hu Y; Nie T; Tang H; Zhu J; Chen K; Liu L; Leong KW; Chen Y; Mao HQ
    Acta Biomater; 2018 Nov; 81():195-207. PubMed ID: 30267888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid nanoparticle purification by spin centrifugation-dialysis (SCD): a facile and high-throughput approach for small scale preparation of siRNA-lipid complexes.
    Mihaila R; Chang S; Wei AT; Hu ZY; Ruhela D; Shadel TR; Duenwald S; Payson E; Cunningham JJ; Kuklin N; Mathre DJ
    Int J Pharm; 2011 Nov; 420(1):118-21. PubMed ID: 21893179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.
    Cheng X; Lee RJ
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical characterization techniques for lipid based delivery systems for siRNA.
    Kapoor M; Burgess DJ; Patil SD
    Int J Pharm; 2012 May; 427(1):35-57. PubMed ID: 21979250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixing.
    Zhigaltsev IV; Belliveau N; Hafez I; Leung AK; Huft J; Hansen C; Cullis PR
    Langmuir; 2012 Feb; 28(7):3633-40. PubMed ID: 22268499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers.
    Maeki M; Fujishima Y; Sato Y; Yasui T; Kaji N; Ishida A; Tani H; Baba Y; Harashima H; Tokeshi M
    PLoS One; 2017; 12(11):e0187962. PubMed ID: 29182626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles.
    Yanez Arteta M; Kjellman T; Bartesaghi S; Wallin S; Wu X; Kvist AJ; Dabkowska A; Székely N; Radulescu A; Bergenholtz J; Lindfors L
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3351-E3360. PubMed ID: 29588418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach.
    Terada T; Kulkarni JA; Huynh A; Chen S; van der Meel R; Tam YYC; Cullis PR
    Langmuir; 2021 Jan; 37(3):1120-1128. PubMed ID: 33439022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells.
    Khare P; Dave KM; Kamte YS; Manoharan MA; O'Donnell LA; Manickam DS
    AAPS J; 2021 Dec; 24(1):8. PubMed ID: 34873640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative analysis of mRNA-lipid nanoparticle stability in human plasma and serum by size-exclusion chromatography coupled with dual-angle light scattering.
    Liau B; Zhang L; Ang MJY; Ng JY; C V SB; Schneider S; Gudihal R; Bae KH; Yang YY
    Nanomedicine; 2024 Jun; 58():102745. PubMed ID: 38499167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of cholesterol-conjugated ionizable amino lipids with biomembranes: lipid polymorphism, structure-activity relationship, and implications for siRNA delivery.
    Zhang J; Fan H; Levorse DA; Crocker LS
    Langmuir; 2011 Aug; 27(15):9473-83. PubMed ID: 21648950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA.
    Kulkarni JA; Darjuan MM; Mercer JE; Chen S; van der Meel R; Thewalt JL; Tam YYC; Cullis PR
    ACS Nano; 2018 May; 12(5):4787-4795. PubMed ID: 29614232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodistribution and metabolism studies of lipid nanoparticle-formulated internally [3H]-labeled siRNA in mice.
    Christensen J; Litherland K; Faller T; van de Kerkhof E; Natt F; Hunziker J; Boos J; Beuvink I; Bowman K; Baryza J; Beverly M; Vargeese C; Heudi O; Stoeckli M; Krauser J; Swart P
    Drug Metab Dispos; 2014 Mar; 42(3):431-40. PubMed ID: 24389421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real time measurement of PEG shedding from lipid nanoparticles in serum via NMR spectroscopy.
    Wilson SC; Baryza JL; Reynolds AJ; Bowman K; Keegan ME; Standley SM; Gardner NP; Parmar P; Agir VO; Yadav S; Zunic A; Vargeese C; Lee CC; Rajan S
    Mol Pharm; 2015 Feb; 12(2):386-92. PubMed ID: 25581130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model.
    Schädlich A; Caysa H; Mueller T; Tenambergen F; Rose C; Göpferich A; Kuntsche J; Mäder K
    ACS Nano; 2011 Nov; 5(11):8710-20. PubMed ID: 21970766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of siRNA-Loaded Lipid Nanoparticles using a Microfluidic Device.
    Maeki M; Okada Y; Uno S; Niwa A; Ishida A; Tani H; Tokeshi M
    J Vis Exp; 2022 Mar; (181):. PubMed ID: 35404350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient siRNA Delivery by Lipid Nanoparticles Modified with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting.
    Sakurai Y; Mizumura W; Murata M; Hada T; Yamamoto S; Ito K; Iwasaki K; Katoh T; Goto Y; Takagi A; Kohara M; Suga H; Harashima H
    Mol Pharm; 2017 Oct; 14(10):3290-3298. PubMed ID: 28789523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.